Tag: VectivBio

Ironwood Pharmaceuticals to acquire Swiss biotech company VectivBio

businessnewstoday- May 22, 2023

Ironwood Pharmaceuticals, a gastrointestinal (GI)-focused healthcare company, has agreed to acquire VectivBio Holding AG, a Switzerland-based biotech company, listed on the Nasdaq, for around $1 ... Read More

VectivBio begins phase 3 trial of apraglutide in short bowel syndrome

pharmanewsdaily- February 3, 2021

VectivBio has dosed the first patient in its phase 3 STARS clinical trial of its synthetic GLP-2 analog apraglutide in short bowel syndrome (SBS). The ... Read More

Pfizer wraps up $810m acquisition of Swiss biotech company Therachon

pharmanewsdaily- July 7, 2019

Pfizer acquisition of Therachon : US pharma giant Pfizer has completed its previously announced acquisition of Swiss biotech company Therachon, which is focused on rare ... Read More